NASDAQ:MZOR Mazor Robotics Stock Forecast, Price & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Mazor Robotics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $58.23 0.00 (0.00 %) (As of 12/19/2018) Add Compare Share Today's Range$58.23Now: $58.23▼$58.2350-Day Range$58.23MA: $58.23▼$58.2352-Week Range$41.60Now: $58.23▼$76.56Volume37 shsAverage Volume292,420 shsMarket Capitalization$1.53 billionP/E RatioN/ADividend YieldN/ABeta1.39 ProfileEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Mazor Robotics Ltd., together with its subsidiaries, engages in the development, production, and marketing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States and internationally. It operates in the field of computer assisted surgery that enable the use of surgical instruments with high precision and minimal invasiveness and that simplifies complex surgical procedures. The company's surgical robotic-guidance systems and complementary products are used to conduct spine and brain procedures in an accurate and secure manner. It also offers Mazor X, a renaissance system and its accessories are used in spine surgeries, including fusion, correction of spinal deformities, biopsy collection, tumor excision, and cement augmentations. The company was formerly known as Mazor Surgical Technologies Ltd. and changed its name to Mazor Robotics Ltd. in 2010. Mazor Robotics Ltd. was founded in 2000 and is based in Caesarea, Israel.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Mazor Robotics. Previous Next 2.1 Community Rank Outperform VotesMazor Robotics has received 314 “outperform” votes. (Add your “outperform” vote.)Underperform VotesMazor Robotics has received 419 “underperform” votes. (Add your “underperform” vote.)Community SentimentMazor Robotics has received 57.16% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Mazor Robotics and other stocks. Vote “Outperform” if you believe MZOR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MZOR will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldMazor Robotics does not currently pay a dividend.Dividend GrowthMazor Robotics does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Mazor Robotics insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 32.68% of the stock of Mazor Robotics is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Mazor Robotics are expected to grow in the coming year, from ($0.38) to $0.17 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Mazor Robotics is -116.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Mazor Robotics is -116.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMazor Robotics has a P/B Ratio of 13.06. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.55 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:MZOR Previous Symbol CUSIPN/A CIK1566844 Webwww.mazorrobotics.com Phone972-4618-7101EmployeesN/A Debt Debt-to-Equity RatioN/A Current Ratio5.49 Quick Ratio5.18Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$64.95 million Price / Sales23.61 Cash FlowN/A Price / Cash FlowN/A Book Value$4.46 per share Price / Book13.06Profitability EPS (Most Recent Fiscal Year)($0.50) Net Income$-12,410,000.00 Net Margins-37.29% Return on Equity-7.70% Return on Assets-6.64%Miscellaneous Outstanding Shares26,330,000Market Cap$1.53 billion Next Earnings DateN/A OptionableOptionable Receive MZOR News and Ratings via Email Sign-up to receive the latest news and ratings for MZOR and its competitors with MarketBeat's FREE daily newsletter. Mazor Robotics (NASDAQ:MZOR) Frequently Asked Questions What stocks does MarketBeat like better than Mazor Robotics? Wall Street analysts have given Mazor Robotics a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Mazor Robotics wasn't one of them. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. How were Mazor Robotics' earnings last quarter? Mazor Robotics Ltd. (NASDAQ:MZOR) announced its earnings results on Thursday, August, 2nd. The medical instruments supplier reported ($0.14) EPS for the quarter, missing the consensus estimate of ($0.01) by $0.13. The medical instruments supplier had revenue of $13.20 million for the quarter, compared to the consensus estimate of $17.02 million. Mazor Robotics had a negative net margin of 37.29% and a negative return on equity of 7.70%. The firm's revenue for the quarter was down 14.8% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.05) EPS. View Mazor Robotics' earnings history. Who are some of Mazor Robotics' key competitors? Some companies that are related to Mazor Robotics include Haemonetics (HAE), Nevro (NVRO), Globus Medical (GMED), Tandem Diabetes Care (TNDM), Inspire Medical Systems (INSP), Integra LifeSciences (IART), ICU Medical (ICUI), ShockWave Medical (SWAV), Inari Medical (NARI), Merit Medical Systems (MMSI), Glaukos (GKOS), Cantel Medical (CMD), NuVasive (NUVA), Silk Road Medical (SILK) and AtriCure (ATRC). View all competitors. What other stocks do shareholders of Mazor Robotics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Mazor Robotics investors own include NVIDIA (NVDA), Intuitive Surgical (ISRG), salesforce.com (CRM), Alibaba Group (BABA), Omeros (OMER), PayPal (PYPL), Advanced Micro Devices (AMD), Canopy Growth (CGC), Micron Technology (MU) and Netflix (NFLX). Who are Mazor Robotics' key executives? Mazor Robotics' management team includes the following people: Mr. Ori Hadomi, CEO & Director (Age 51)Mr. Eliyahu Zehavi, Co-Founder & Exec. VP of Advanced Technologies (Age 63)Ms. Sharon Levita, CFO, VP of Bus. Operations & Company Sec. (Age 51)Dr. Doron Dinstein M.D., Chief Medical Officer (Age 47)Mr. Christopher Prentice, Chief Commercial Officer (Age 48) What is Mazor Robotics' stock symbol? Mazor Robotics trades on the NASDAQ under the ticker symbol "MZOR." What is Mazor Robotics' stock price today? One share of MZOR stock can currently be purchased for approximately $58.23. How big of a company is Mazor Robotics? Mazor Robotics has a market capitalization of $1.53 billion and generates $64.95 million in revenue each year. The medical instruments supplier earns $-12,410,000.00 in net income (profit) each year or ($0.50) on an earnings per share basis. What is Mazor Robotics' official website? The official website for Mazor Robotics is www.mazorrobotics.com. How can I contact Mazor Robotics? Mazor Robotics' mailing address is 5 SHACHAM STREET NORTH INDUSTRIAL PARK, CAESAREA L3, 3088900. The medical instruments supplier can be reached via phone at 972-4618-7101 or via email at [email protected] This page was last updated on 11/24/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
